Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000170481 | SCV000756679 | uncertain significance | Beta-hydroxyisobutyryl-CoA deacylase deficiency | 2018-02-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been reported as homozygous in an individual affected with 3-Hydroxyisobutryl-CoA hydrolase deficiency (PMID: 26026795). ClinVar contains an entry for this variant (Variation ID: 190268). This variant is present in population databases (rs757976755, ExAC 0.003%). This sequence change replaces arginine with tryptophan at codon 66 of the HIBCH protein (p.Arg66Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. |
Bonnen Lab, |
RCV000170481 | SCV000196891 | pathogenic | Beta-hydroxyisobutyryl-CoA deacylase deficiency | 2014-12-30 | no assertion criteria provided | research | Decreased HIBCH enzymatic activity in fibroblasts. |
OMIM | RCV000170481 | SCV000245423 | pathogenic | Beta-hydroxyisobutyryl-CoA deacylase deficiency | 2015-08-01 | no assertion criteria provided | literature only |